• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

High survival rates in trial of new heart valve
Loyola University Medical Center is the only Chicago hospital participating in a landmark clinical trial of an artificial aortic heart valve that does not require open heart surgery. First results from the trial were announced at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco. Results were positive, with high survival rates and low rates of stroke. "This is a major breakthrough," said Fred Leya, MD, co-principal investigator at the Loyola site. "Not only did patients live longer, but their quality of life improved substantially...
Source: Health News from Medical News Today - November 7, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news

Second generation transcatheter aortic valve shown to successfully address complications of TAVR
Results of the REPRISE II trial reported at TCT 2013 In a clinical trial, a second-generation transcatheter aortic valve demonstrated low rates of complications that are sometimes seen in transcatheter aortic valve replacement (TAVR), including challenges with positioning, post-procedure paravalvular aortic regurgitation, vascular complications, and stroke. The findings were presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium...
Source: Health News from Medical News Today - November 5, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Medtronic CoreValve U.S. Pivotal Trial results reveal positive outcomes for patients
Medtronic, Inc. (NYSE: MDT) has announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on the Medtronic CoreValve® System. The study of the novel self-expanding device, presented at a late-breaking clinical trial session of the Transcatheter Cardiovascular Therapeutics (TCT) 2013 Conference, met its primary endpoint in patients who were considered too ill or frail to have their aortic valves replaced through traditional open-heart surgery, with a rate of death or major stroke at one year of 25.5 percent...
Source: Health News from Medical News Today - November 1, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

COREVALVE reduces rate of death and stroke in sickest patients with aortic stenosis
In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at "extreme risk" for surgery. Results of the COREVALVE EXTREME RISK trial were presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine...
Source: Health News from Medical News Today - October 31, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Statin therapy prior to CABG surgery may improve outcomes
Patients receiving statin therapy before coronary artery bypass grafting (CABG) surgery appear to have a reduced risk of post-surgical mortality, stroke, and atrial fibrillation (irregular or rapid heart rate), according to an article in the October 2013 issue of The Annals of Thoracic Surgery. These same benefits from statins could not be demonstrated for patients undergoing aortic valve replacement (AVR). "Heart surgery patients typically have a number of other disorders, so we need to optimize the patient's preoperative condition and help ensure the best possible result," said Elmar W...
Source: Health News from Medical News Today - October 1, 2013 Category: Consumer Health News Tags: Statins Source Type: news

TAVR Vs Standard Surgery: Midterm Stroke, Death Rates Comparable
All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented at the American College of Cardiology's 62nd Annual Scientific Session. The transcatheter aortic valve replacement (TAVR) system was investigated as an alternative to open-heart surgery for high-risk patients with severe aortic stenosis - narrowing of a main circulatory gateway in the heart that reduces blood flow...
Source: Health News from Medical News Today - March 14, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news